New Dollar-A-Dose Rotavirus Vaccine Attains Clinical Success In India

Stanford Medicine’s “Scope” blog discusses results of a study recently published in The Lancet on the efficacy of a rotavirus vaccine in India. The vaccine was spearheaded by an Indian biotechnology company, Bharat Biotech, and “has leaped the safety and efficacy thresholds of a late-stage clinical trial, in which more than 6,500 Indian infants were…More

See the rest here:
New Dollar-A-Dose Rotavirus Vaccine Attains Clinical Success In India